These include the direct regulation of Mdm2 and Akt2 as well as the regulation of genes such as Stat3 and Rhpn2, which are involved in GBM Mesenchymal transformation and as downstream effectors of GBM genomic lesions, respectively [59, 60]. Here, MDM2 is linked to glioblastoma.